Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neurologic Toxicities of Immunotherapy.
Harrison RA, Majd NK, Tummala S, de Groot JF. Harrison RA, et al. Adv Exp Med Biol. 2021;1342:417-429. doi: 10.1007/978-3-030-79308-1_18. Adv Exp Med Biol. 2021. PMID: 34972978
Cell Signaling Pathways in Brain Tumors.
Harrison RA, de Groot JF. Harrison RA, et al. Top Magn Reson Imaging. 2017 Feb;26(1):15-26. doi: 10.1097/RMR.0000000000000112. Top Magn Reson Imaging. 2017. PMID: 28079711 Review.
Treatment of Glioblastoma in the Elderly.
Harrison RA, de Groot JF. Harrison RA, et al. Drugs Aging. 2018 Aug;35(8):707-718. doi: 10.1007/s40266-018-0568-9. Drugs Aging. 2018. PMID: 30039343 Review.
Pre-surgical connectome features predict IDH status in diffuse gliomas.
Kesler SR, Harrison RA, Petersen ML, Rao V, Dyson H, Alfaro-Munoz K, Weathers SP, de Groot J. Kesler SR, et al. Among authors: harrison ra. Oncotarget. 2019 Nov 5;10(60):6484-6493. doi: 10.18632/oncotarget.27301. eCollection 2019 Nov 5. Oncotarget. 2019. PMID: 31741712 Free PMC article.
Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Weathers SP, Penas-Prado M, Pei BL, Ling X, Kassab C, Banerjee P, Bdiwi M, Shaim H, Alsuliman A, Shanley M, de Groot JF, O'Brien BJ, Harrison R, Majd N, Kamiya-Matsuoka C, Fuller GN, Huse JT, Chi L, Rao G, Weinberg JS, Lang FF, Sawaya R, Shpall EJ, Rezvani K, Heimberger AB. Weathers SP, et al. Clin Cancer Res. 2020 Jul 15;26(14):3565-3577. doi: 10.1158/1078-0432.CCR-20-0176. Epub 2020 Apr 16. Clin Cancer Res. 2020. PMID: 32299815 Free PMC article. Clinical Trial.
A first-in-human Phase I trial of the oral p-STAT3 inhibitor WP1066 in patients with recurrent malignant glioma.
Groot J, Ott M, Wei J, Kassab C, Fang D, Najem H, O'Brien B, Weathers SP, Matsouka CK, Majd NK, Harrison RA, Fuller GN, Huse JT, Long JP, Sawaya R, Rao G, MacDonald TJ, Priebe W, DeCuypere M, Heimberger AB. Groot J, et al. Among authors: harrison ra. CNS Oncol. 2022 Jun 1;11(2):CNS87. doi: 10.2217/cns-2022-0005. Epub 2022 May 16. CNS Oncol. 2022. PMID: 35575067 Free PMC article. Clinical Trial.
Patterns of failure after radiation therapy in primary spinal high-grade gliomas: A single institutional analysis.
Upadhyay R, Khose S, Pokhylevych H, Paulino AC, McAleer MF, Ghia A, Li J, Yeboa DN, Loghin M, Harrison R, O'Brien B, Kamiya-Matsuoka C, De Groot J, Puduvalli VK, Tatsui C, Alvarez-Breckenridge C, Prabhu S, Rhines L, Zaky W, Lin F, Weinberg JS, Fuller G, Sandberg DI, Johnson JM, McGovern SL. Upadhyay R, et al. Neurooncol Adv. 2022 Aug 20;4(1):vdac129. doi: 10.1093/noajnl/vdac129. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36128585 Free PMC article.
439 results